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Oligonucleotide-directed mutagenesis of the l-lactamase gene, bla, on pBR322 was used to change the codon
for the active-site serine 70, AGC, to CGC, coding for arginine. Escherichia coli cells carrying the mutant
plasmid, pGD104, were sensitive to ampicillin, indicating that the arginine-containing enzyme is inactive. We
characterized the reversion of the mutant bla gene by a number of mutagens and in different genetic
backgrounds and demonstrated that full ampicillin resistance can be restored only by a G. C-to-T * A
transversion occurring at the first base of the codon. Thus, reversion of the mutant bla gene is diagnostic for
G. C-to-T- A transversions, and bacteria carrying pGD104 can be used as test strains to detect the occurrence
of this mutation.
Studies of mutational specificity have contributed greatly
to the understanding of the mutagenic process. The classic
determination of the spatial distribution of mutations in the
rII gene of bacteriophage T4 (5), the elegant genetic analysis
of forward mutations in the lacI gene of Escherichia coli
(11), and the use of trpA alleles to detect specific base
substitution mutations (1) have provided extensive informa-
tion about the nature of both induced and spontaneous
mutagenesis. Recently, Salmonella typhimurium strains
have been developed that can be used to test for the ability
of mutagens to induce each of the six possible base substi-
tution events (33). These and other systems to determnine
mutational specificity can be utilized to deduce the nature of
mutagenic DNA lesions and the biochemical pathways by
which they are processed (reviewed in reference 18). How-
ever, a comprehensive genetic analysis of mutational path-
ways is difficult when using the somewhat cumbersome
systems developed to date. Consequently, we sought a way
to detect easily the unambiguous occurrence of a specific
class of mutation in a variety of different genetic back-
grounds. We choose to develop a test plasmid for G C-to-
T * A transversions, but the method is applicable to all six
possible base substitution events.
To detect specifically a given mutational event, a genetic
system has to meet two criteria. First, the mutation must
yield a selectable phenotype. Second, to detect a specific
base substitution, the resultant phenotype must depend on
the identity of only one DNA base pair. To meet these
criteria, we drew upon the wealth of knowledge about the
enzymatic activity of class A ,-lactamases and chose as a
mutational target the gene for this enzyme, bla, on pBR322.
We created by oligonucleotide-directed mutagenesis (12) a
specific mutation in the codon for serine 70 (using the
numbering of the consensus sequence [2]; residue 70 [2]
corresponds to codon 68 [52]). Ser-70, essential for P-
lactamase activity, is part of a conserved triad (Ser-Thr-Xaa-
Lys) found in class A P-lactamases at the catalytic site (2).
* Corresponding author.
Hydrolysis of the P-lactam ring of penam and cephem
antibiotics occurs via an acyl-enzyme intermediate formed
between the Ser-70 hydroxyl group and the carbonyl carbon
of the P-lactam ring (22, 31). Cysteine is the only other
residue known to substitute for Ser-70 in this reaction,
yielding an enzyme with 1/30th of the wild-type activity (12,
13, 49, 50). The wild-type codon is AGC (52), which we
mutated to CGC (arginine), yielding an inactive enzyme.
Only a G * C-to-T. A transversion at the first base of this
codon can revert the arginine to serine. Other base substi-
tutions at the first base give cysteine and glycine, base
substitutions at the second base give leucine, proline, and
histidine, and base substitutions at the third base are silent.
Based on the mechanism of enzyme action, only a G * C-to-
T A transversion, restoring serine, would be expected to
revert the ampicillin-sensitive (Aps) phenotype to full
ampicillin resistance (Apr).
G * C-to-T * A transversions are not well induced by most
mutagens commonly used to mnutagenize bacteria. The base
substitutions induced by direct-acting mutagens, i.e., those
that do not require SOS processing for their mutagenicity,
are almost exclusively transitions (15). Several SOS-
dependent mutagens, such as UV light, 4-nitroquinoline-1-
oxide, and neocarzinostatin, also preferentially induce tran-
sitions, but can induce transversions at low frequencies (10,
23, 24). However, a number of SOS-dependent mutagens,
including several known carcinogens, induce high frequen-
cies of G - C-to-T * A transversions. This mutation is virtu-
ally the only base substitution induced by aflatoxin Bi
(AFB1) (25); it is a major component of the mutagenic
spectrum of benzo[a]pyrene, cyclopenta[cd]pyrene, and cis-
diamminedichloroplatinum (II) (6, 19); and it is induced by
depurination (48). In addition, it is the most frequent base
substitution recovered after the induction of the SOS system
in the absence ofDNA damage (44). These findings have led
to the hypothesis (reviewed in reference 37) that depurina-
tion at guanines, or the occurrence of noninformational
lesions at guanines, is a common intermediate in the mutage-
nicity of all these agents and treatments; the induction of
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TABLE 1. Plasmids used in this study
Plasmid Description Drug resistance Reference
pGD104 pBR322 with mutant bla gene Tetracycline This paper
pSE137 umuDC cloned on a pSC101 derivative Spectinomycin 20
pSE155 mucAB cloned on a pSC101 derivative Spectinomycina S. J. Elledge, personal communication
pGW270* pKM101 derivative with a nonrevertable Kanamycin 32; this paper
mutation in the bla gene
a pSE155 has low-level tetracycline resistance that makes pGD104 slightly unstable in strains with both plasmids.
transversion mutations can be explained by the preferential
incorporation of dATP opposite such sites. Hence, an easy
and rapid method to detect the occurrence of G. C-to-T. A
transversions would be useful to: (i) find other mutagens that
induce this event; (ii) identify DNA repair functions that may
prevent its induction; and (iii) screen for mutants affected in
the pathway that processes DNA lesions to give this muta-
tion.
In this paper we report the creation of a mutation in the bla
gene giving CGC, coding for arginine, at residue 70. We
characterize the induction of Apr revertants with a number
of mutagens and show that the mutation is reverted by
agents that induce G- C-to-T. A transversions. Finally, the
sequences of a number of revertant plasmids are confirmed
to be AGC, serine, at residue 70.
MATERIALS AND METHODS
Bacterial strains. E. coli K-12 AB1885 (F- uvrB5 thr-J
leu-6 proA2 his4 thi-J argE3 lac YJ galK2 ara-14 xyl-5 mtl-l
tsx-33 strA31 sup-37 A- [30]) was used throughout. PF501, a
recA441 sulAJI (= tif sfi) derivative, was made by: (i) P1
transduction to recA430 srl::TnlO from GW2727 (obtained
from G. Walker), selecting for tetracycline resistance (Tet')
and screening for UV sensitivity and the inability to use
sorbitol (Srl-); (ii) P1 transduction to recA441 from GC3217
(27), selecting for Srl+ and screening for UV resistance and
Tets; (iii) P1 transduction to pyrD34 zcb-222::TnJO from
CY307 (obtained from D. Brash), selecting for Tetr and
screening for inability to grow without uracil (Ura-); (iv) P1
transduction to sulAlI from GC3217 by selecting for Ura+
and screening for Tet' and nonfilamentation at 42°C in
minimal medium with 100 ,ug of adenine per ml. Genetic
methods were as described previously (42).
Plasmids. The plasmids used are listed in Table 1.
pGW270* is an Aps derivative of pGW270 (32), which is a
derivative of the mutagenesis-enhancing plasmids R46 and
pKM101 (46). pGW270* was constructed by cutting pGW270
DNA with EcoRI, filling in the overhang with DNA poly-
merase I large fragment, and religating with T4 ligase. Ap5
kanamycin-resistant plasmids were then screened for the
ability to restore mutability to a umuC36 strain. Plasmid
DNA preparation and manipulations and bacterial transduc-
tions were as described previously (39, 45).
Oligonucleotide-directed mutagenesis. pBR322 was mu-
tated in vitro with a 15-base synthetic oligonucleotide (5'-
ATGATGCGCACTTTT-3', antisense of nucleotides 3946 to
3960 [52]), containing the desired mutation (at nucleotide
3954) to prime DNA synthesis as described previously (12).
The presence of the desired mutation in the plasmid was
confirmed by DNA sequencing. Cells carrying the mutant
plasmid, pGD104, were Aps Tetr.
Bacterial mutagenesis. Bacteria were grown in LB broth
with drug selection for plasmids until the mid-log phase (50
Klett units). Cells were then centrifuged and suspended at
lOx in E salts (54) or, for N-methyl-N'-nitro-N-nitrosoguani-
dine (MNNG) experiments, 0.1 M citrate buffer (pH 5.5).
Approximately 2 x 107 cells were exposed to the mutagen
for 5 min at room temperature for MNNG and methyl
methanesulfonate (MMS), 20 min at room temperature for
dibromoaflatoxin, 60 min at 37°C in the presence of meta-
bolic activation buffer containing 60 p.l of rat liver
microsomes per ml (3) for AFB1, and the designated period
of time for UV light. Chemical mutagen-exposed cells were
then centrifuged and washed once with E salts or, for
MNNG experiments, 0.1 M phosphate buffer (pH 7). Sur-
vival titers of samples were determined on LB plates, and in
some experiments, samples were plated on Vogel-Bonner
minimal plates (54) supplemented with 4 puM arginine and 10
jig of other required amino acids per ml to select for arginine
prototrophy. The remaining cells were inoculated into 5-ml
LB broth plus drugs and grown overnight at 37°C. Samples
were then plated on LB plus ampicillin (50 mg/liter) and, in
some experiments, LB plus rifampin (100 mg/liter), and titers
were determined on LB plus tetracycline (20 mg/liter). In
two UV experiments and tif experiments (see below), a
sample from the overnight culture was plated on supple-
mented Vogel-Bonner minimal plates without arginine to
score for arginine prototrophs. The medium was as de-
scribed previously (42).
Tif induction. Early-log-phase cultures grown in supple-
mented Vogel-Bonner minimal medium plus tetracycline (10
mg/liter) at 32°C were divided in half and grown for 2 h at
32°C and at 42°C with 100 ,ug of adenine per ml added.
Approximately 108 cells were then inoculated into 5 ml of the
same medium and grown overnight at 32 and 37°C (42°C is
eventually lethal). The rest of the procedure was as for
mutagen-treated cells.
Sequencing. Plasmid DNA was prepared from single-
colony-purified revertants or nonreverted bacteria and trans-
formed into JM109 (59). After single-colony purification of
transformants, plasmid DNA was prepared and cut with
HincII and EcoRI. The 450-base-pair fragment containing
the mutated site was purified in low-melting-temperature
agar and ligated into HincII-EcoRI-cut and phosphatased
M13mp8 DNA. The ligated DNA was transformed into
JM109, and white plaques were picked and sequenced by the
standard dideoxy technique (47). Two to five plaques of each
revertant were sequenced. Methods were as described pre-
viously (39, 41; or instructions from the suppliers).
RESULTS
By changing the AGC Ser-70 codon to CGC (arginine) we
created a G- C base pair as a mutational target. The sur-
rounding sequence is 5'-GCGC-3'/5'-GCGC-3' (52). Table 2
compares reversion of this mutant bla gene with the induc-
tion of rifampin resistance (Rift) or arginine prototrophy
(Arg+) by several mutagens. Rifampin resistance can arise
from a number of mutations in the rpoB gene (4, 7). The
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argE3 mutation is an ochre that can be reverted by base
substitutions at the site or by the creation of several
extragenic tRNA suppressors (53). The mutagens used were
chosen for their base substitution specificity as follows.
MNNG. At the concentrations used, MNNG induces
G * C-to-A T transitions owing to the strongly mutagenic
lesion 06-methylguanine (10, 38). A T-to-G * C transitions
are induced at 1/10th the frequency of G. C-to-A - T transi-
tions (10) and may be due to miscoding by 04-methylthymine
(51) or the misincorporation of 06-methyl-dGTP (17).
MNNG showed no apparent site specificity in its ability to
induce nonsense mutations in the lacI gene (10). Reversion
of the mutant bla gene was not induced by this mutagen.
MMS. MMS has been shown to induce a number of
different base substitutions (53). Its mutagenicity is thought
to be due, at least in part, to spontaneous or enzymatic
depurination of 7-methylguanine and 3-methylpurines (15,
16), which would be expected to yield transversions. As
predicted, MMS reverted the mutant bla gene approximately
16-fold above background.
UV light. UV light induces transition mutations at adjacent
pyrimidines (11). The target site of the mutant bla gene does
not contain a pyrimidine pair. However, UV light also
induces transversions at low frequencies, and these muta-
tions do not require the presence of adjacent pyrimidines
(11, 24, 43). It was therefore an unexpected result that UV
TABLE 2. Reversion of the mutant bla gene induced by various
mutagens compared with induction of rifampin resistance
and arginine prototrophy
Straina Mutagen Surviving
Mutants per 108 cellsStrain (concn) fraction Apr Rj Arg+
AB1885 MNNG
0 ,ug/ml 1.0b llb 2
50 ,ug/ml 1.3b 13b 77 2,078b,d
100 ,ug/ml 0.85b 17b 470 6,394b,d
AB1885 MMS
0% 1.OC 6c 2
5% 0.59c 159c 136 9od
AB1885 UV light
0 s 1.OC 13C <1 3
1 s 0.42c 8c 160 175
2 s 0.04c 8C 249 405
AB1885 AFB1
0 RM 1.0 4 <1
10,lM 0.3 3 1
100 ,M 0.03 4 5
AB1885(pSE137) 0 ,M 1.0 <1 <1
10 ,uM 0.39 2 5
100 ,uM 0.02 4 16
AB1885(pSE155) 0 ,uM 1.0C 166C 21c
10 puM 0.85c 224C 208C
100 JIM 0.02c 697c 497c
AB1885(pGW270*) Br2AFLe
0 ,uM 1.0b 25b
100 JIM 0.32b 168b
a All strains also carry pGD104.
b Average of three determinations.
c Average of two determinations.
dDetermined on plates containing limiting arginine. Mutations arising
spontaneously on the plates have been subtracted.
e Br2AFL, Dibromoaflatoxin.
TABLE 3. Reversion of the mutant bla gene and induction
of arginine prototrophy under conditions than enhance
SOS mutagenesis
Mutants per
Straina Mutagen Surviving 108 cells(concn) fraction
Apr Arg+
PF501 tif
320C 1.Ob 6b 3
42°C + adenine 0.44b 29b 27
AB1885(pGW270*) MNNG
0 ,ug/ml 1.0 15
50S,g/ml 1.1 15 1,963c
100 ,ug/ml 0.83 21 6,537c
AB1885(PGW270*) MMS
0% 1.0 15
5% 0.66 1,071
AB1885(PGW270*) UV light
0 s 1.0 71 51
1 s 0.65 65 1,390
2 s 0.31 58 1,112
a All strains also carry pGD104.
b Average of two determinations.
c Determined on plates containing limiting arginine. Mutations arising
spontaneously on the plates have been subtracted.
light did not revert the mutant bla gene. The DNA lesion that
gives rise to UV light-induced transversions appeared not to
be formed at the mutant bla target site. Alternatively,
UV-induced lesions occurring on a multicopy plasmid may
be readily repaired by some recombinational pathway.
AFB1. The base substitutions induced by AFB1 are almost
exclusively G C-to-T. A transversions (25). Like MNNG,
metabolically activated AFB1 showed very little site speci-
ficity in the induction of nonsense mutations in the lacI gene
(25). Aflatoxin mutagenicity is dependent on the presence of
the mutagenesis-enhancing mucAB operon from pKM101
(25); the presence of the analogous operon from E. coli,
umuDC, has little effect (P. L. Foster and E. Eisenstadt,
unpublished observations). As predicted, metabolically ac-
tivated AFB1 reverted the mutant bla gene, but only if
mucAB was present.
Also shown in Table 2 is the frequency of Apr revertants
induced by dibromoaflatoxin, a direct-acting aflatoxin with
the same mutagenic specificity and approximately 1/10th the
mutagenic potency of metabolically activated AFB1 (P. L.
Foster, J. M. Miller, E. Davis, W. Barnes, and J. Groopman,
manuscript in preparation). The DNA sequence of plasmids
isolated from Apr revertants induced by dibromoaflatoxin
was determined in the region of interest (see below).
The results presented in Table 2 and previous studies (44,
48, 53) suggested that an enhanced level of SOS mutagenic
processing is necessary for the induction of G * C-to-T. A
transversions. In Table 3 are presented reversion frequen-
cies of the mutant bla gene under conditions that enhance
SOS mutagenesis. The first of these was thermal induction of
a strain (recA441, previously known as tif) that expresses all
SOS functions constitutively at 42°C in the presence of
adenine (8). This treatment, which has been shown to result
in G - C-to-T A transversions (44), caused a fivefold in-
crease in the frequency of reversion of the mutant bla gene.
In the other experiments presented in Table 3, the activi-
ties ofmucAB were enhanced by the presence of this operon
on plasmid pGW270*. Since the parent of pGW270,
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pKM101, does not appear to have a general effect on the
SOS response (28, 36, 57), the rest of the functions of the
SOS system presumably remained at normal mutagen-
induced levels in these experiments. The frequency of MMS-
induced reversion of the mutant bla gene was increased
10-fold by the presence of pGW270*, confirming the results
of Todd et al. (53) that MMS-induced G * C-to-T * A
transversions were enhanced by plasmid R46 (an ancestor of
pGW270*). However, pGW270* had no such effect when
cells were exposed to MNNG or UV light, mutagens that did
not revert the mutant bla gene without the plasmid (cf. Table
2). These results indicate that a high level of mucAB activity
is not of itself sufficient to induce G. C-to-T - A transver-
sions but that a specific lesion in the DNA must also be
present. That is, the events that revert the mutant bla gene
appear to be targeted to the site of a DNA lesion.
HinclI-EcoRI fragments from the original mutant plasmid,
eight independent dibromoaflatoxin-induced revertants, and
eight independent spontaneous Apr revertants [from
AB1885(pGW270*)] were subcloned in M13mp8, and several
independent clones generated from each plasmid were se-
quenced. The sequence of the nonreverted plasmid was
confirmed to be CGC (arginine) at nucleotides 3952 to 3954
with no other sequence differences from pBR322 between
nucleotides 3909 and 4055 (52). All eight dibromoaflatoxin-
induced and four spontaneous revertants were AGC (serine)
at 3952 to 3954, also with no other detected differences from
pBR322. Four spontaneous revertants gave both CGC and
AGC sequences in approximately a 1:1 ratio. Agarose gel
electrophoresis after a very limited DNaseI digestion of
these plasmids showed that they were larger than the original
pGD104. Thus, they were most likely dimers containing one
reverted and one nonreverted site.
DISCUSSION
Replacement of serine 70 by arginine in P-lactamase
resulted in an inactive enzyme. The requirement for serine in
the ,-lactamase catalytic site and the characteristics of the
genetic code allow pGD104, carrying the mutant bla gene
with CGC (arginine) at residue 70, to function as a specific
test plasmid for G C-to-T. A transversions. AFB1 and
MMS, both known to induce this base substitution, reverted
the mutant bla gene, whereas MNNG, which induces tran-
sitions, did not. Induced and spontaneous revertants con-
tained the wild-type sequence, which could only arise via a
G. C-to-T- A transversion.
Several studies (reviewed in reference 37) have suggested
the following hypothetical pathway for the induction of
transversion mutations. Certain mutagen-damaged bases are
spontaneously or enzymatically converted to apurinic or
apyrimidinic (AP) sites in vivo. AP sites also arise sponta-
neously or after in vitro treatment of DNA with, for exam-
ple, heat at low pH. AP sites can be bypassed during
replication because DNA polymerase inserts nucleotides
opposite such sites if the SOS response has been induced.
The order of preference of insertion, shown for a number of
polymerases in vitro, is A > G > T >> C. Hence, if the
missing bases are purines, transversion mutations result.
Thus, for example, the induction of G * C-to-T * A transver-
sions by AFBl (25) can be explained by its strong preference
for making adducts to the N-7 of guanines (21, 35, 40), the
resultant lability of the glycosylic bond leading to loss of the
base (29), and the insertion of adenine by DNA polymerase
opposite the AP site. (This hypothesis does not strictly
require that depurination or depyrimidination occurs, since
it is possible that any noninformational lesion could be
similarly bypassed.)
Mutations that arise via this hypothesized pathway can
only be recovered if the SOS response is induced. Thus, an
alternative hypothesis is that the mutations are untargeted;
that is, they may arise not at the sites of missing or damaged
bases, but as a result of an error-prone polymerase replicat-
ing undamaged DNA. However, the G C-to-T * A transver-
sions that are well induced by AFB1 and benzo[a]pyrene and
that result from induction of the SOS response in the
absence ofDNA damage do not occur at the same sites, and
thus must be targeted (reviewed in reference 44). Our finding
that UV light, which is a strong inducer of the SOS response
(58), does not revert the mutant bla gene (Tables 2 and 3)
demonstrates that, similarly, the mutations we are detecting
here are targeted.
The mutagenicity of SOS-dependent mutagens requires
the functions of the umuDC operon, which are induced as
part of the SOS response (reviewed in reference 56). The
analogous operon, mucAB, from plasmid pKM101 appears
to be more active in promoting both spontaneous and
induced mutations (55, 57) (Tables 2 and 3), an effect that is
unlikely to be due to enhanced induction of the SOS re-
sponse (reviewed in reference 56). We had previously ob-
served that mutagenesis by AFB1 was particularly depen-
dent on the presence of mucAB (25); umuDC, even when
present in the same copy number, had little effect (Fbster
and Eisenstadt, unpublished observations). The results
shown in Table 2 confirm this dependence of aflatoxin
mutagenicity on mucAB activity. However, enhancement of
induced mutagenicity by mucAB is not nonspecific: the
presence ofpGW270* had no effect on the induction of either
Apr or Arg+ mutations by the SOS-independent mutagen
MNNG and had different effects on the frequencies of
mutations induced by the SOS-dependent mutagens MMS
and UV light (Tables 2 and 3). Specifically, the presence of
the plasmid enhanced MMS-induced reversion of the mutant
bla gene but did not change the inability of UV light to
induce this mutation. In contrast, the induction of Arg+
revertants by both MMS and UV light was increased by
pGW270*. Thus, mucAB-enhanced mnutagenesis after expo-
sure to a mutagen appears to occur only at the sites ofDNA
lesions that are substrates for SOS processing. We are
currently using the mutant bla gene to explore the nature of
this mucAB-enhanced mutagenesis.
As has been previously observed with other mutational
targets (26, 46, 55), the presence of mucAB also enhanced
spontaneous reversion of the mutant P-lactamase gene (Ta-
bles 2 and 3). In contrast, spontaneous Apr reversions were
not increased by the umuDC clone, although present on the
same vector as pSElSS. It would appear that the biochemical
activities encoded by the umuDC operon are normally
limiting for spontaneous as well as induced mutagenic pro-
cesses but that these activities can be supplied by the mucAB
gene products (55). Our data confirm those of Fowler et al.
(26) that G * C-to-T. A transversions are at least one of
these spontaneous events enhanced by mucAB. As has been
suggested for the transversion mutations that occur after the
induction of the SOS response (44), these mutations may be
the result of replication past cryptic DNA lesions, possibly
spontaneously occurring apurinic sites, that only produce
mutations when SOS mutagenic processing is active. Thus,
control of the levels or activities or both of the umuDC and
mucAB gene products may be an important determinant of
the spontaneous mutation rate of a cell. In this regard, it is
interesting that pSE155 was up to 10 times more active than
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pGW270 in enhancing both spontaneous and induced rever-
sion of the mutant bla gene, although both plasmids occur in
approximately the same copy number (9, 34). This result
suggests that some control function or antagonistic activity
present on pGW270 and its parent, pKM101, was lost when
the mucAB operon was cloned. Interestingly, a negative
control function on plasmid R46 apparently also is missing
from its deletion derivative, pKM101 (14).
The techniques we developed are generally applicable to
studies of mutagenesis. The plasmid we constructed to
detect G C-to-T A transversions is just one of a number of
test plasmids that can be made by oligonucleotide-directed
mutagenesis of the codon for the active-site serine of ,B-
lactamase. Mutants to specifically detect three more base
substitutions can be created by making a single base change
in the AGC (Ser) codon. For example, changing the AGC to
GGC (Gly) would yield a mutant that could be reverted only
by G C-to-A T transitions. Because serine is also speci-
fied by the family of TCX codons, seven more mutant
plasmids to detect all six possible base substitution events
can be constructed. Once made, these plasmids can be
further mutated to alter the sequence context of the target
base by changing the base in the wobble position of the
codon. Thus, such test plasmids will be useful for studying
base substitution specificity, the effects of local DNA se-
quence on mutagenesis, and the role of various bacterial
genes in the induction of mutations. Finally, the techniques
are also applicable to other genes and DNA sequences, such
as promoters, in which the identity of one base pair is
essential to function.
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